1. GBp

    1,653

    Today's change

    -5.50 / -0.33%

    1 year change

    +27.55%

    As of Aug 25 2016 17:07 BST. Data delayed by at least 20 minutes.

Search for GlaxoSmithKline PLC and
  1. August 10, 2016

    The Zika virus — where did it come from and where will it end?

    Let’s start at the beginning. Where did Zika come from? Like so many emerging viruses, Zika came out of Africa. It was...

  2. August 1, 2016

    Saatchi sexism row: older guys should adjust mindset

    Many older men will have read the news that Kevin Roberts, chairman of ad group Saatchi & Saatchi, has been placed on...

Special Reports

  1. Responsible Business

    The winners of the 2016 Responsible Business Awards range from a waste company’s susta...
  2. Combating Cancer

    We consider the latest in cell therapy and efforts to arm the immune system in the fig...
Search more Special Reports on this topic.

  1. August 1, 2016

    GSK and Alphabet strike electrifying tie-up in bioelectronics

    Until now the pharmaceutical industry has lived off pills and injections. Since the 19th century its scientists have...

  2. August 1, 2016

    Google and GSK create a world leader in bioelectronics

    Last week GlaxoSmithKline, Britain’s largest drug company, committed to invest a further £275m in its UK manufacturing...

  3. August 1, 2016

    GSK teams up with Alphabet for bioelectronics venture

    GlaxoSmithKline has teamed up with Alphabet, Google’s holding company, to treat disease through miniature implants that...

  4. FT Alphaville

    August 1, 2016

    FT Opening Quote: GSK and Alphabet to develop bioelectronics

    GSK and Alphabet team up, a week of post-Brexit results and BOE expected to cut rates. FT Opening Quote, with...

  5. Fast FT

    August 1, 2016

    GSK teams up with Alphabet in £540m bioelectronic deal

    A powerful new force in bioelectronics – using electrical signals rather than chemical or biological drugs to treat...

  6. July 28, 2016

    The Brexit reckoning: UK plc reports

    UK companies with a combined market value of £500bn reported results yesterday — and revealed stark differences in how...

  7. Fast FT

    July 28, 2016

    AstraZeneca insists new drugs 'advancing quickly' as revenues drop

    Loss of market exclusivity on key products, as well as restructuring costs, have weighed on first half results from UK...

  8. July 27, 2016

    GSK to invest £275m in UK as sales grow for new drugs

    GlaxoSmithKline, the largest UK drug company, is to invest £275m to expand production capacity at three British sites...

  9. Fast FT

    July 27, 2016

    GSK beats expectations in second quarter

    Shares in GlaxoSmithKline jumped as much as 2.4 per cent at lunchtime after it reported Q2 results well ahead of...

  10. FT Alphaville

    July 27, 2016

    FT Opening Quote: GSK signals post-Brexit confidence

    GSK announces UK investment, Taylor Wimpey shrugs off Brexit concerns and Arm Holdings revenues are up. FT Opening...

  11. Fast FT

    July 27, 2016

    GSK invests in UK sites in vote of confidence in Brexit Britain

    GlaxoSmithKline, the largest UK drug company, is to invest an extra £275m at three British manufacturing sites, in a...

  12. Fast FT

    July 27, 2016

    Fast Europe Open: UK GDP and earnings galore

    Two suspected Islamist assailants have murdered an 86-year-old priest in a Catholic church in Normandy. The men, armed...

  13. July 22, 2016

    UK-exposed stocks sink on slowdown fears

    Businesses most exposed to the UK economy fell on Friday as indications of a post-referendum slowdown started to appear...

  14. Fast FT

    July 12, 2016

    Sterling advance cools FTSE 100

    The FTSE 100’s weak sterling-fuelled outperformance has hit the buffers today, as the blue chip index dips into the red...

  15. Fast FT

    July 5, 2016

    Sterling plunge drives equity divergence

    The post-referendum sterling rout has driven a sharp divergence in UK equity performance, with companies that earn...

  16. June 24, 2016

    Few bright spots in UK traders’ sea of red

    As a sea of red swept across City traders’ screens on Friday, investors took refuge in the few stocks with sufficient...

  17. Fast FT

    June 20, 2016

    Opening Quote: sparkly sterling; Electra shake-up; Majestic Wine

    Sterling and markets are surging as sentiment swings back towards a Remain vote in the UK’s EU referendum. FT Opening...

  18. FT Alphaville

    June 20, 2016

    FT Opening Quote

    Sterling and markets are surging as sentiment swings back towards a Remain vote in the UK’s EU referendum. FT Opening...

  19. Fast FT

    June 14, 2016

    GSK's head of vaccines to depart next year

    The head of vaccines at GlaxoSmithKline, Moncef Slaoui, has told the UK drugmaker that he intends to step down in June...

  20. June 7, 2016

    Responsible Business Awards case studies

    PwC’s restaurant shows street cred The lives of more than 850 homeless people in London have been transformed by...

  21. FT Alphaville

    June 3, 2016

    Markets Live: Friday, 3rd June, 2016

    This Markets Live session ended at 12:01 on 3 Jun 2016. Participants in this session were: Paul Murphy and Bryce Elder...

  22. June 2, 2016

    Oncology takes lead in exploring potential of epigenetics

    The past five years have been a golden age in cancer genetics. The cost of gene sequencing has fallen low enough for...

  23. May 19, 2016

    Pull together to prevent a superbug apocalypse

    Jim O’Neill, UK Treasury minister and former Goldman Sachs economist, has focused the world’s attention on...

  24. Fast FT

    May 17, 2016

    Epstein out as Novartis splits cancer from pharma unit

    Swiss pharmaceuticals group Novartis announced on Tuesday plans to separate its oncology unit from its pharmaceuticals...

  25. May 10, 2016

    Progress on maternal mortality hindered by ‘funding mismatch’

    When thousands of delegates travel to the latest Women Deliver conference in Copenhagen this month, they will see both...

  26. May 3, 2016

    Witty looks to cement his legacy as GSK’s performance improves

    Sir Andrew Witty’s final 11 months in charge of GlaxoSmithKline will not be the victory lap he might have hoped for...

  27. April 29, 2016

    GlaxoSmithKline’s mouthwash to be life saver for babies

    A brand of mouthwash has been reformulated by GlaxoSmithKline into an antiseptic gel that could save hundreds of...

  28. April 27, 2016

    GSK chief says pressure on US drug prices to rise

    Pressure on drug prices in the US will continue to grow regardless of who wins November’s presidential election, the...

  29. April 27, 2016

    Sir Andrew Witty fuels GSK turnround hopes with results boost

    Sir Andrew Witty began his final year in charge of GlaxoSmithKline with a stronger than expected rise in first-quarter...

  30. Fast FT

    April 27, 2016

    GlaxoSmithKline Q1 growth aided by HIV drugs

    Sir Andrew Witty began his final year in charge of GlaxoSmithKline with a stronger-than-expected rise in first quarter...

  31. April 25, 2016

    Drug prices: Tweaking the formula

    What is the value of a human life? It is one of the most fraught questions in public policy as governments around the...

  32. April 25, 2016

    Vaccine development needs global alliance

    Who has saved the most lives in human history? Claims can be made for various scientific pioneers and political...

  33. April 25, 2016

    Vaccines are among big pharma’s best-selling products

    Ask people to name Pfizer’s best-selling product and many would opt for one of its most famous drugs: Viagra, for...

  34. April 24, 2016

    WHO stays positive as dose of reality hits malaria vaccine hopes

    It should be a time for optimism among those engaged in the fight against malaria. Incidence of the disease fell 37 per...

  35. April 19, 2016

    The secret of a world-class biotech sector

    Britain, it is often said, has world-class science but too few world-class science-based companies. Nowhere is this...

  36. April 3, 2016

    GSK returns to battle against cancer

    When GlaxoSmithKline agreed to sell its oncology drugs to Novartis for $16bn in 2014, it looked like the UK...

  37. April 1, 2016

    GSK to allow staggered payments for EMA-approved gene therapy

    GlaxoSmithKline is to allow health systems to make staggered payments for one of Europe’s first gene therapies in a...

  38. March 31, 2016

    GSK to relax intellectual property and help developing world

    GlaxoSmithKline has promised not to seek patent protection on medicines in low-income countries as part of measures by...

Search for GlaxoSmithKline PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Sir Andrew Witty’s strategy for returning GlaxoSmithKline to ...
    May 11, 2015

    Sir Andrew Witty’s strategy for returning GlaxoSmithKli...

  2. Today’s top headlines from the FirstFT briefing...
    February 4, 2015

    Today’s top headlines from the FirstFT briefing

  3. Pharmaceuticals group announces cost cutting...
    October 22, 2014

    Pharmaceuticals group announces cost cutting